Elliot Tapper @ebtapper

@Will_Sanchez_MD ❤️

We have an amazing team @Austin_Health linkedin.com/posts/austin-h…

Psa: Dutch licorice is bad

@IrisWangMD @MayoClinicGIHep @DougSimonetto @DarrellPardi Question for a friend, are those tats for sale?

💪

Mayo Clinic Gastroenterology & Hepatology @MayoClinicGIHep

7 days ago

Congratulations to our 2026 Fellows’ Choice award winners! 🎉 Each year, fellows recognize faculty who have made a meaningful impact on their education—those who go above and beyond to teach and inspire. 👏 Teacher of the Year: Dr. Doug Simonetto 👏 Endoscopy Teacher of the

keyboard_arrow_left Previous keyboard_arrow_right Next

0 8 44 13K 0

Yes is crucial for career development and thriving in medicine No can protect you. but a deliberate yes, even when it makes you nervous, opens doors. Below is our framework on how to yes

Elliot Tapper @ebtapper

2 years ago

No is having a moment right now However! Yes remains a powerful tool for academic and personal growth. We felt that it was time to lay out a strategy for how best to yes in academic medicine journals.lww.com/ajg/citation/9…

1 33 113 31K 44

It runs in families. Dr. Tu shows that having a PARENT die from alcohol-related liver diseases puts the CHILD at higher risk of alcohol misuse and worse outcomes from alcohol-associated hepatitis Nature or Nurture? The answer is yes.

🔥 HOT TOPIC 📘 @HepCommJournal A promising advance for #Wilsondisease, this Phase 2 trial found that tiomolibdate safely eliminated excess copper and improved copper balance in patients with this devastating disorder of copper metabolism. The findings could help pave the way for more effective treatment strategies to prevent progressive liver and neurologic damage. Read the article here ➡️ journals.lww.com/hepcomm/fullte… @Thomas_Sandahl

Co-Editors @ebtapper and Carmen Chak-Lui Wong share exciting science from the June issue of @HepCommJournal featuring a newly developed disease-specific health-related quality of life questionnaire for people with #ALD, results from the MIDAS trial, two must-read papers on symptom management, emerging neutrophil-targeted therapies, research on epigenetic drugs that reduce Th17-driven fibrosis in cirrhosis, and more. #LiverTwitter Watch below and view the latest issue here: journals.lww.com/hepcomm/pages/… youtube.com/watch?v=dXQEO5…

🚨GI/Hep Fellowships start in 2️⃣ weeks‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp is back❕ First up, #Endohepatology Learn EUS-guided: Liver biopsy 💉 Portal pressure 📏 Variceal treatment 🩸 Elastography and more! journals.lww.com/hepcomm/fullte…

keyboard_arrow_left Previous keyboard_arrow_right Next

Steady increase in IF from 12.9 to 18 in last 3 years. Dr Gores team has set a very strong foundation for the next team led by Dr Nagy and I to accelerate our journey to the top. It is just a matter of when, not if. Please send your best science to us.

AASLD @AASLDtweets

a week ago

🎉 Just Released: @HEP_Journal has achieved its highest-ever #ImpactFactor! The premier journal for #liverdisease research, HEPATOLOGY continues to publish the discoveries, innovations, and clinical insights that are shaping the future of liver health. Learn more about

1 10 59 6K 1

🎉 Just Released: @HEP_Journal has achieved its highest-ever #ImpactFactor! The premier journal for #liverdisease research, HEPATOLOGY continues to publish the discoveries, innovations, and clinical insights that are shaping the future of liver health. Learn more about #HEPATOLOGY: bit.ly/4pWNKzD

🎉Congratulations @HepCommJournal on achieving its highest #ImpactFactor ever! From emerging discoveries to practice-changing research, #hepatologyCommunications delivers timely, high-impact science through its fully #OpenAccess platform, connecting the global #hepatology community with the latest advances in liver health. @ebtapper Learn more: bit.ly/4uLkZb3

@RajivJalan1 Thank you sir

I am always on vacation when these are released - grateful to Tarryn @ the @Wolters_Kluwer team for sending me the results so I can get back to watching my kids at the pool! FYI @DrCynthiaLevy your pbc review was top 2, @JuDongYang1, your review on AFP was a top 3 cited paper

Impact factor is not everything But it is something The impact factor of @HepCommJournal has reached its all time high of 6.0 With thanks to the associate editors, reviewers and authors who made this possible

Standard 💩 transplant by colonoscopy beats vanc taper, fidaxomycin, and newer FMT approaches for recurrent c diff in a cost-effectiveness analysis by @UMichGIHep Bill Hirsh and my former neighbors, Radha and Byron academic.oup.com/cid/advance-ar…

Surgical friends, Can we PLEASE stop saying “surgical clearance” instead of “surgical risk stratification” and PLEASE stop asking primary care to fax a letter of “clearance” for every young, healthy person undergoing surgery. This behavior is WILD.

🧠 Hepatic Encephalopathy Series (Part 1/4): Diagnosis There is no single diagnostic test for overt hepatic encephalopathy (HE). A practical 4-step approach: 1️⃣ Define the underlying liver disease 2️⃣ Characterise the neurological syndrome 3️⃣ Identify precipitants 4️⃣ Exclude alternative diagnoses 🔗 fg.bmj.com/content/17/4/3… ⚠️ Not every confused patient with cirrhosis has HE. #FrontlineGastroenterology #Hepatology #Cirrhosis #HepaticEncephalopathy @basl_events @heppharm @livernursing @LiverAHPs @Liver4Lifeuk @f4liverresearch @IQILS_Liver @LiverTrust @EASLedu @EASLnews @BritSocGastro @BavenoCoop @BCLC_group @ILCAnews @APASLnews @liverfellow @my_ueg @UKCPAGastro @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BSGtrainees @drkeithsiau @ebtapper @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @ClinicLiver

Some brief thoughts on this study (longer reflections later) about how the frontier model vs domain-specific model conversation interacts with the broader notion of AI in clinical practice. 1. The ability to personally manipulate how models respond is remains underrated Any trainee through the medical system will know that the way information is communicated, analyzed, and acted on can vastly differ from physician and speciality. That aspect of communication -- what details to reinforce, what values to skip, how to communicate differential diagnoses in an objective manner -- is a function of many factors, one of which is trust in the presenter. As each physician uses these tools to augment their own personal style of thinking, the ability to shape and structure the manner in which these tools convey answers will directly impact how effective and preferable using these tools will be. To that extent -- frontier LLMs, which offer at least some degree of steering model outputs via custom instructions, projects, etc. -- will naturally have an advantage. Allowing clinicians to manipulate these workflows such that they can better intuit where the tools may fail vs be useful will be huge. [0] [0] x.com/samarthrawal/s… 2. LLMs are superhuman persuaders "i expect ai to be capable of superhuman persuasion well before it is superhuman at general intelligence" - Sam Altman We have definitely crossed this point, at least with using LLMs to answer clinical questions: for a particular question, chances are there will be some paper on some data that can positively affirm the implicit bias within that question. And since models are remarkably capable at synthesizing complex information into a cohesive narrative, they will be able to give a very reasonable-sounding answer to a clinical question, whether or not it is truly applicable in that scenario (ie, has reasonable external validity). Relying on personal clinical "preference" to select an LLM tool of choice can therefore be quite dangerous, because a style of answer may not correlate with the applicability of the answer. This is something I try to be cognizant of whenever I use LLMs, particularly in the clinical setting, in order to be watchful against this error mode. ([1] Related slides - How I use LLMs in Clinical Research & Practice - x.com/samarthrawal/s…) 3. The boundary between answering a question and clinical reasoning is blurry even before the adoption of LLMs, there was always a bit of grey area between looking up information and clinical decision-making. For example: an article on UpToDate will give you basic facts and data about a particular condition, but also segue into next steps (thereby helping clinicians reason about problems). By itself, this is not a bad thing - in fact, it can be very valuable. Now though, tools are able to remarkably synthesize facts, studies, empiric results, and clinical guidelines into a single, cohesive answer. Where does answering a question stop, and making a decision based on explicit and implicit phrasing of the clinical question end? This undoubtedly reshapes how we think about clinical practice, and therefore being aware of this process will be extremely important to clinicians moving forward, in my opinion. (some more on this topic here - [2] samrawal.com/blog/augmentin…)

Eric Topol @EricTopol

2 weeks ago

For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @EvidenceOpen and @UpToDate as assessed by 12 US clinicians, randomized and blinded to which model and extensive testing/benchmarks. This was not anticipated.

118 529 2K 828K 1K